<SEC-DOCUMENT>0001097149-22-000044.txt : 20220712
<SEC-HEADER>0001097149-22-000044.hdr.sgml : 20220712
<ACCEPTANCE-DATETIME>20220525162158
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001097149-22-000044
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20220525

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALIGN TECHNOLOGY INC
		CENTRAL INDEX KEY:			0001097149
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				943267295
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		410 NORTH SCOTTSDALE ROAD, SUITE 1300
		CITY:			TEMPE
		STATE:			AZ
		ZIP:			85281
		BUSINESS PHONE:		408-470-1000

	MAIL ADDRESS:	
		STREET 1:		410 NORTH SCOTTSDALE ROAD, SUITE 1300
		CITY:			TEMPE
		STATE:			AZ
		ZIP:			85281
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5fc397e594be4b03bb13c0852ceb09ba_1"></div><div style="min-height:117pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><img alt="sec1.jpg" src="sec1.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:576px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">FOIA Confidential Treatment Requested by Align Technology, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Pursuant to 17 C.F.R. &#167;200.83</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.594%"></td><td style="width:0.1%"></td></tr><tr style="height:110pt"><td colspan="3" rowspan="5" style="padding:0 1pt"><div style="margin-bottom:0.08pt;padding-left:36pt"><img alt="sec2.jpg" src="sec2.jpg" style="height:680px;margin-bottom:5pt;vertical-align:text-bottom;width:20px"></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Securities &#38; Exchange Commission</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Division of Corporation Finance</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Office of Life Sciences</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">100 F Street, N.E.</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Washington, D.C.  20549</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">May 25, 2022</font></div></td></tr><tr style="height:37pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:400;line-height:120%"> </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ms. Christie Wong<br>Mr. Michael Fay</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:69pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Re&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Align Technology, Inc.<br>Form 10-K for the Fiscal Year Ended December 31, 2021<br>Filed February 25, 2022<br>File No. 000-32259</font></td></tr><tr style="height:248pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Dear Ms. Wong and Mr. Fay&#58;</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">On behalf of Align Technology, Inc. (&#8220;Align&#8221;), I respectfully submit this letter in response to the comment from the staff (the &#8220;Staff&#8221;) of Securities and Exchange Commission (the &#8220;Commission&#8221;) received by letter dated April 29, 2022, issued in response to Align&#8217;s letter dated April 21, 2022, in response to the Staff&#8217;s initial comment letter dated March 31, 2022, all relating to Align&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the &#8220;Form 10-K&#8221;) filed with the Commission on February 25, 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In this letter, Align has recited the comment from the Staff in italicized, bold type and has followed the comment with Align&#8217;s response. Capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Form 10-K, as applicable.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Align is requesting confidential treatment for certain figures included in Align&#8217;s response to the Staff&#8217;s comment, which have been redacted and replaced with bracketed asterisks (&#8220;&#91;***&#93;&#8221;).  Pursuant to Rule 83 of the Commission&#8217;s Rules on Information and Requests (17 C.F.R. &#167;200.83), Align has provided the unredacted response to the Staff under separate cover and a separate letter to the Office of Freedom of Information and Privacy Act Operations in connection with the confidential treatment request.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">1</font></div></div></div><div id="i5fc397e594be4b03bb13c0852ceb09ba_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><img alt="sec3.jpg" src="sec3.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:103px"></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.019%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.073%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:125%;text-decoration:underline">Form 10-K for the Fiscal Year Ended December 31, 2021</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:125%;text-decoration:underline">Consolidated Financial Statements</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:125%;text-decoration:underline">Revenue Recognition, page 68</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:125%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:125%;padding-left:9.75pt">We have reviewed your response to prior comment 1 and note that you estimate usage, which requires significant judgment. For each of the periods presented, please tell us your estimated usage rates. If multiple types of estimated usage rates are used, please explain how these were determined. In addition, tell us the approximate impact to revenue from any period over period changes in estimated usage rates.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">Response&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Align offers our Invisalign system in a variety of treatment packages which treat different severity levels of malocclusion. The packages consist of an initial set of aligners that are capable of completing the approved treatment, and for most packages, also include the option to order additional aligners if the patient&#8217;s treatment deviates from the original treatment plan. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The number of optional additional aligners included in the list price and the time allowed for additional aligner order submission are defined in the terms and conditions for each product which vary by region and country. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Align has the historical experience to estimate the number of additional aligners that will be requested by our customers, which include General Practitioner dentists and Orthodontists (collectively &#8220;doctors&#8221;). The usage rate is the average number of additional aligners orders requested for each treatment and is expressed as a percentage. For example, if two additional aligners orders are delivered on average for each set of initial aligners, the usage rate is 200%.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">To determine usage rates on a quarterly basis, we begin with historical information regarding the average number of additional aligners requested by doctors for treatments. We establish usage rates based on products with similar terms and conditions. In addition, we review usage rates by region, country, and doctor channels to identify if there are significant differences in usage behavior. More details about our approach by product type are discussed below&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%;text-decoration:underline">Invisalign Comprehensive</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The Invisalign Comprehensive product is used to treat a wide spectrum of mild to severe malocclusion and includes the option to order an unlimited number of additional aligners for a period of five years after the initial aligner shipment. To determine the estimated Invisalign Comprehensive additional aligner usage rates, we review the historical additional aligner usage over a five-year period from the initial aligner shipment. Five years is used since this is the length of time defined in the terms and conditions when an additional aligner order can be submitted. The number of additional aligner orders associated with each initial aligner shipment is tracked to identify customer behavior trends.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><img alt="sec3.jpg" src="sec3.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:103px"></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.019%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.073%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In addition to the quarterly review of existing rates, we periodically review if certain regions, countries and&#47;or doctor channels have significantly different additional aligner usage behavior that may require new estimated usage rates to be established. As an example of a geographic difference, Japan Comprehensive has its own usage rate since doctor behavior there is different from the rest of the APAC region. In addition, we identified differing usage rate trends between our two main North American doctor channels&#58; Orthodontists and General Practitioner dentists. Therefore, we have established six usage rates for Invisalign Comprehensive based on these identified characteristics.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%;text-decoration:underline">Invisalign First Phase I and Invisalign First Comprehensive Phase 2</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Invisalign First Phase I is specifically designed for younger patients between the ages of seven and ten years and provides early interceptive orthodontic treatment. The product includes the option to order an unlimited number of additional aligners within 18 months of shipment of the initial aligners. Invisalign First Comprehensive Phase 2 is complementary to First Phase I and is generally consistent with our Invisalign Comprehensive product. It includes the option to order an unlimited number of additional aligners within three years of shipment of the initial aligners.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">To determine these estimated usage rates, we reviewed historical information for the length of time when an additional aligner can be submitted, 18 months and three years, respectively. Since doctor behavior was similar among all regions, countries, and channels, we established a global usage rate for each of Invisalign First Phase I and Invisalign Comprehensive Phase 2.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%;text-decoration:underline">Non-Comprehensive Invisalign</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Our non-comprehensive products are for less complex orthodontic cases, non-comprehensive relapse cases, or straightening prior to restorative or cosmetic treatments and include our Invisalign Express, Lite, Go, Go Plus, and Moderate products. The availability of the products, the number of additional aligners that are included in the list price, and the timing of additional aligner order submission can vary and are determined by regional and country terms and conditions. These product offerings generally provide the option to obtain one or two sets of additional aligners within a period of six months to three years from the initial aligner shipment. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">     </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">To establish estimated usage rates for the non-comprehensive products, we reviewed historical trends for the length of time that an additional aligner order can be submitted. We noted that doctor behavior was generally similar across all regions, countries and channels. Therefore, usage rates were established according to the number of optional additional aligner orders included in the list price and length of time allowed to submit additional aligner orders from the initial aligner shipment date. Based on these considerations, we have established eleven usage rates for these products.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In addition to reviewing historical information by product and treatment length as outlined above, we also review doctor behavior from the last 12 months. If the review shows a change in behavior, we make further adjustments to the estimated usage rate if the changes are anticipated to be reflective of future expected behavior. Any changes in the estimated usage rates are applied prospectively at the beginning of the subsequent quarter. In addition, we compare the estimated usage rate to the actual usage rates after each quarter and no material differences have been identified to date. </font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><img alt="sec3.jpg" src="sec3.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:103px"></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.019%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.073%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Overall, we currently have 19 estimated usage rates based on the criteria outlined above. On a weighted basis, the average estimated usage rate used is &#91;***&#93;%, &#91;***&#93;%, and &#91;***&#93;% for the years ended December 31, 2021, 2020, and 2019 respectively. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The estimated impact to revenue as a result of period over period changes to the usage rate estimates is less than $15 million on an annual basis for each year presented, and immaterial to our financial statements. Since usage rates are updated quarterly as needed, there is not a material cumulative impact to any one quarter. </font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">If the Staff would like any additional information or has any further questions, please do not hesitate to contact me at (408) 470-1006.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Yours truly,</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%;text-decoration:underline">s&#47; John F. Morici</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">John F. Morici</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Chief Financial Officer and Executive Vice President, Global Finance</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cc&#58;  </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Joseph M. Hogan, Align Technology, Inc. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Julie Coletti, Align Technology, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Lindsey Piziali, PricewaterhouseCoopers LLP</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Chris Fennell, Wilson Sonsini Goodrich &#38; Rosati </font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:25.2pt"><font><br></font></div><div style="padding-left:25.2pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:0.8pt;padding-left:25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>sec1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sec1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$$17AI9@  34T *@    @ ! $[  (
M   3   (2H=I  0    !   (7IR=  $    F   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %-U8F%D<F$@
M4W)I;FEV87-A;@    60 P "    %   $*R0!  "    %   $,"2D0 "
M S$Q  "2D@ "     S$Q  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                               R,#(R.C T.C T(#$W.C,Q.C U #(P
M,C(Z,#0Z,#0@,3<Z,S$Z,#4   !3 '4 8@!A &0 <@!A "  4P!R &D ;@!I
M '8 80!S &$ ;@   /_A"R5H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M #P_>'!A8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H:4AZ<F53>DY4
M8WIK8SED)S\^#0H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O
M(CX\<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO
M,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/CQR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2)U=6ED.F9A9C5B9&0U+6)A,V0M,3%D82UA9#,Q+60S,V0W-3$X,F8Q
M8B(@>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O
M(B\^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z9F%F-6)D9#4M
M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SIX;7 ](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B/CQX;7 Z0W)E871E1&%T93XR,#(R
M+3 T+3 T5#$W.C,Q.C U+C$P-CPO>&UP.D-R96%T941A=&4^/"]R9&8Z1&5S
M8W)I<'1I;VX^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z9F%F
M-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SID8STB
M:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/CQD8SIC<F5A=&]R
M/CQR9&8Z4V5Q('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P
M,B\R,BUR9&8M<WEN=&%X+6YS(R(^/')D9CIL:3Y3=6)A9')A(%-R:6YI=F%S
M86X\+W)D9CIL:3X\+W)D9CI397$^#0H)"0D\+V1C.F-R96%T;W(^/"]R9&8Z
M1&5S8W)I<'1I;VX^/"]R9&8Z4D1&/CPO>#IX;7!M971A/@T*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" \/WAP86-K970@96YD/2=W)S\^_]L 0P '!04&!00'
M!@4&" <'" H1"PH)"0H5#Q ,$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL
M*QH@+S,O*C(G*BLJ_]L 0P$'" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\  $0@ /P)2
M P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*"__$
M +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A""-"
ML<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=8
M65IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JR
ML[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY
M^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (! @0$
M P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)R
MT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H
M:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BY
MNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "
M$0,1 #\ ^D:*** "BBB@ HHHH ***S+GQ)HEG>BSN]8L8+DG'DR7**V?H30!
MIT57CO[.6Z:VBNX'G09:)9 6 ]QU[BO)?AM=W,WQK\80S7,TD49FV1O(2J_O
MAT!X% 'L5%<CX0T7^S-7U.8:['J7G-S'')N*')Y;DX/;\ZWM0U_1])E6+5-4
ML[.1ONI/.J$_@36E2,8RM%W7<QH3G4AS5(\K[;FA155=4T]Y8HDOK9I)E#1(
M)E)<'H0,\CCM2RZG803M!->V\<J+N:-Y5#!<9R1GICFLS8LT50T_7M)U:1TT
MO4[.\=/O+!.KE?J :OT %<OJ]W<1?$CPW:QSR);S6]V98E<A7*JFTD=#C)Q7
M45R.M_\ )4O"W_7M>_\ H*4 ==1BBD=UC1GD8*JC+,QP /6@!<45G_\ "0:-
M_P!!:Q_\"4_QJS:WUI?*S65U#<!3AC#('Q]<4 3X'I1BBB@ P/2C%%% !BC%
M%0V]W;7:L;2XBG"-M8QN&VGT..] $V!Z48HHH ,48'I110 8HQ4+WEM%=1VT
MEQ$D\@RD3. S?0=34U !BC%%% !BC%%% !BC ]*** #%&*KG4+,2S1&[@$D"
M[I4\T9C'JPSP/K4D%Q#=0K-;31S1-]UXV#*?Q% $F*,444 &*,#THHH ,#TH
MP/2D+!5+,0 !DD]JCMKJWO(?-M)XIX\XWQ.&&?J* )<#THP/2BB@ P/2C ]*
M** # ]*,#TI"0JDL0 !DD]JCMKNWO(?-LYXIX\XWQ.&&?3(H EP/2C ]***
M"BBJW]I6.9Q]LM\V_P#KAYJ_NO\ >YX_&@"S13(9HKB%9;>1)8W&5=&#!A[$
M4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* .2^)_B"Y\-?#W4+ZP8I=,%ABD'5"Y W?4 D_6N"\!?!S0M;\&VVK>(FN;F
M\U%#-N68KY8/3ZGN2<UZ;XT\-IXM\(WVCM((GG0&*0CA'4[E)]LCGVKRGPYX
ME^(?@C3%\-3^#Y]2-N2EK,JL5 STW*"&7\1Q0!!\+]$?P[\<]7TF29K@VMK(
MBRMU=<QE<^^"*TOAE_R7+QE]9O\ T<*;\-?#_BNU^+6HZOXITZ:%[FWD,EQM
M_=EV*$*I'' X_"M/X?>']7T[XO\ BK4+[3KBWL[HR^1/(F%DS*",'OQS0!S?
MPRU/^Q+[XA:FBAFM$>90>Y5Y2!^=+\,_AW8^/M.O/$WC">XO9KFX=%42E>1U
M8D<]3@#H *V/AKX0U&/5O&=OKVFW-I::F&C1Y4VB16:3)7\&!K)T"?QU\)Y[
MO1D\.S:YITDID@D@5B"3QD%0<9 &5(ZTP*4/A&+P9^T#H>G6LTDUHS":W\TY
M9$*N-OX$'\ZG\7^'[?Q/^T<NDWKO';W$4?FF,X9E6'<5S[XQ52QNO$&H_'[0
M[OQ3:BTO9RKI:J<^1%L?:I'8\$\\\UV-QX?U=OVD(=973K@Z:(0#=[/W8/D$
M8S]>* .6\9>%K+X;?$3PQ>^%WF@6YF :-Y"V,.H89/.&#8(-?0->4_%[0-6U
MCQ+X6FTK3KB[BMIRTSPIN$8WQG)].A_*O5J0!7(ZW_R5+PM_U[7O_H*5UU<C
MK?\ R5+PM_U[7O\ Z"E '75%=VT5[9S6MPNZ&>-HY%SC*L,$?D:EHH ^?_B%
M\/?#?A_Q9X4L=+LFBM]1NO*N5,S-O7>@QDGCACTKJ]9U+2?@Q>V-AX<T%YX]
M8=FE5;AF<LF H4'.2=V*M?$W1-4U3QIX-N=.L)[F"TO-]Q)$F1$N^,Y;TX!_
M*I/B!HNI:C\1O!5W96,UQ;6=TS7,J)E8AN0Y8]NA_*F!9N?&OBJ/2]+C@\'R
MMK-^7+P/(1!:JK$ O)C ) SCBJVD?%"[N+?Q';:OI,5MJVA6S7#Q0W'F12@#
M. PZ=O7K6=\3].U:Z\::5->:;JFK^&$A(FL],9MQERW+ $$_P_D>:P=#\+ZK
M%J/C*2V\+76D6=]HSQV-L5W9) PN<GYSU(]<T@-5OC+X@&@6_B$>$,:+O$<]
MP;GJV['R#&<=LD8SQ6_KGQ)NQKVGZ+X4TZWO;N\LUO0][<"",1L,J!ZG%85W
MX<UE_P!FZ'1DTRY.I +FT"?O!^_W=/IS5/Q'H,[P>'X_$7@N?5=.BTJ"(W.G
M!Q>6\H091@&P0#GJ._6@#2\6>,?$6H_"S63+X?GTN\@?[->EY"JI&>/,C; W
M@GY<#US5#P?XEA^'OPIL[N;0@EUJ<JBSAAN-[7[%1^\/79Z8^GK5;2?#?B3_
M (5=XNLQ8ZFMG=,G]E6%X=]P%#Y/';C'Y&K^M>#==N/AMX-O-.LF?5?#XCE>
MPDX9_NDC'J"HX^M,#;M?B-KFE>(-/TWQWX>328]4;9:W,%P)%#<?*WIR0.O?
MI4#?%/5[CQGJ/AW1_#+7\]E=>49$FPHB#89VXX[8%9>M#7OBCX@T*V_X1N_T
M73].N!<75Q?+M.>/E7UZ8_'MBMOP%HNI:?\ $OQI?7UC-!;7EPK6\TB864;F
M.5/?J*0%2\^*>ORZUKVEZ!X66_ETB5@\OVC"B-206(P.3C@#WJB_QHUJX\.)
MKVF>$S)IMN52^N)+C"JY(&U,<D<CG'>M'P?H6JV?BOQ_/=Z?/##?2,;5W3 F
M&9/N^O4?G6%HWAC7(?V=M6T>;2KI-1EN"R6IC_>,-\9R!] ?RI@;E_KVD:I\
M3_!ER-)\ZXU"Q\^VNVG96@5@QV[!PW?KZU2B^+OB/4H-4;0O"*W0TN5Q<2_:
M/D6-<\] 2QP3@9XJ&Q\-ZU'XS^'MR^F7*PV&EK%=2&/B!]K?*WH>15[X=Z!J
MVF^&?&4-_IUQ;RW=S.UNDB8,H*$ CUH N77Q?MU\"Z7K-CILEQJ&J3&VM[ /
M_P M5.&^;'(R1CCG(J.'XE^([+Q5HV@>)?"\=A<:E,%\U+G>FPD#*XSR.XSZ
M5Q4'A34K#X;^'9KB6WTC7-,U.6>UM-2D$/VC+*=HW'KE5JYK&I>)=4^+7@S_
M (2C3K;39$N,PVD$PE8#(W.Q!. <<?0T >F>/O&G_"&:7:R0V@N[N^N!;V\;
MR"--Q[LQZ 5GZ-XT\0M?W-CXD\.?972U:Y@N[24S6\FT$[2^, \>O]*?\4K&
M]OO#]NMMX>@U^U6<-=6K;A,J_P!Z(J00W4=^O3K7">$?#NHP>+;B;PSH^N:3
MH)T^9+FWU-L>;(48*J+WY*^O0T@+R?&GQ!<>&O[>M?"*MIMO+Y=W<&Y^522
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M>HHH **** "BBB@ K!\3^"M"\7QQ#7+/S9(,^5-&Y21,]@P[>U;U% '/>&/
MN@>$&F?1;,I/.,23RR&21AZ9/;V%=#110 5QNM_"GPGKVJ2ZA>6,D=Q,<S-;
MSM&)3ZL <5V5% %'1]&T_0-+BT[2+5+6UBSMC3WZDGJ2?4U>HHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
$B@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>sec2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sec2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$$17AI9@  34T *@    @ ! $[  (
M   3   (2H=I  0    !   (7IR=  $    F   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %-U8F%D<F$@
M4W)I;FEV87-A;@    60 P "    %   $*R0!  "    %   $,"2D0 "
M S4V  "2D@ "     S4V  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M&7]_;+,LJHP..&'!!Z_C6C6/X3>.3PK8/;ZO)K,)B_=WTJJKRKGC<% &1T/
M/'/.:V* "N'L](\:^'+<Z7X?;0KS34D<VTM\TL<L2LQ;:RH"'P3C.5SWYKN*
M\V\0:]XNT6^%C!K^CW^I39:WTRTT:22=ESP6_P!( 1?5VP/Y4 =GX9T9]!T&
M*RGN!=3^9)-/,$V!Y)':1R%[#<QP/2M:L?PO_P ) = A;Q>;+^U&),BV*L(T
M&>%Y)R0.IZ5L4 %>,6NDZ+9WMSJ5C%XOM-'O+LK-K4.J[$DD+[-Y4-YA3=P&
M(Z<].:]GKQS4+;5-'D1-1T/7X?#7V]#]A.H61MD+2@J68?O!%O(.TM@=.G%
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MI$P);R/,7'(# $9.#F@#TKPYH$/AS2?L4-Q/=.\KSSW-P09)I78LSM@ <D]
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MF/0@'LE%%% !7(7/@6[U%O+U;Q=K-[8M*LDEFR6Z(X5@P4LD0;&0.AS77T4
'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>sec3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sec3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$$17AI9@  34T *@    @ ! $[  (
M   3   (2H=I  0    !   (7IR=  $    F   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %-U8F%D<F$@
M4W)I;FEV87-A;@    60 P "    %   $*R0!  "    %   $,"2D0 "
M S8X  "2D@ "     S8X  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                               R,#(R.C T.C T(#$X.C$V.C(R #(P
M,C(Z,#0Z,#0@,3@Z,38Z,C(   !3 '4 8@!A &0 <@!A "  4P!R &D ;@!I
M '8 80!S &$ ;@   /_A"R5H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M #P_>'!A8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H:4AZ<F53>DY4
M8WIK8SED)S\^#0H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O
M(CX\<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO
M,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/CQR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2)U=6ED.F9A9C5B9&0U+6)A,V0M,3%D82UA9#,Q+60S,V0W-3$X,F8Q
M8B(@>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O
M(B\^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z9F%F-6)D9#4M
M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SIX;7 ](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B/CQX;7 Z0W)E871E1&%T93XR,#(R
M+3 T+3 T5#$X.C$V.C(R+C8W-CPO>&UP.D-R96%T941A=&4^/"]R9&8Z1&5S
M8W)I<'1I;VX^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z9F%F
M-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SID8STB
M:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/CQD8SIC<F5A=&]R
M/CQR9&8Z4V5Q('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P
M,B\R,BUR9&8M<WEN=&%X+6YS(R(^/')D9CIL:3Y3=6)A9')A(%-R:6YI=F%S
M86X\+W)D9CIL:3X\+W)D9CI397$^#0H)"0D\+V1C.F-R96%T;W(^/"]R9&8Z
M1&5S8W)I<'1I;VX^/"]R9&8Z4D1&/CPO>#IX;7!M971A/@T*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" \/WAP86-K970@96YD/2=W)S\^_]L 0P '!04&!00'
M!@4&" <'" H1"PH)"0H5#Q ,$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL
M*QH@+S,O*C(G*BLJ_]L 0P$'" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\  $0@ + !G
M P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*"__$
M +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A""-"
ML<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=8
M65IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JR
ML[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY
M^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (! @0$
M P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)R
MT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H
M:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BY
MNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "
M$0,1 #\ ^D:*** "BD#J<X8''7FL+Q3JMUI=O:/9.JF6;8Q*@Y&* -ZBJ$IU
M ZI#Y+1_9-OS@XS_ (^E7BP7[Q ^IIM6)C*]]!:*,CUI"R@$D@ =>:10M% .
M1D<BB@ HHHH **** "N:\8WMS%#9V-I(8FO9=C.#R!P,?^/"NEK(\1:(=9LD
M$,GE7,#;XG]_3_/I0!@ZSX4CTO1);FQN[@2HH\S<_$@SSP*K:N2WA#02Q))D
M&2?H:O7FF^*=5T]K2[DM8T4#)4\RD>I__54]]X=O;CP_I=G'Y7FVK R9;CIV
MI##478>/M,4,0IBY&?9JI6%B?%NJWMSJ,\HMX)-D42-C'7'\JV;S2+F?Q59:
M@FSR($VOEN<\]OQJE)HNKZ3JUQ<Z \+PW!W/#*?NG_)-,"II]C)I?CZ*T^TR
M31"%FC\QLD+@\5!IFD)K>OZQ'>7$XABG;"(^,DLW\L5)I,=X?B #?SI/<+"6
ME\O[L?&-OZBMO0M(N=.U;5+BXV>7=2[H]K9.-Q//YT@*/@]Y;?4-4TQI6EBM
M9,1ENW)']*ZNL/1M(N;#7=4NY]GE73[H]K9.,D\_G6Y3$%%%% !1110 4444
M %%%% !6'J7AE+^^>Z34+NV>0 ,(WP#@8K<HH S-'T&TT57-OO>63[\LARS5
2IT44 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
